Introduction To determine the stage at the time of diagnosis, comparing them before and during COVID 19 pandemia.

Methods This is a retrospective, observational, and descriptive study carried out at the Marie Curie Hospital in Buenos Aires. There were included all cases of cervical cancer diagnosticated between July 2019 and December 2021. There were analyzed the stages at the time of diagnosis according to FIGO 2018 and compared them and the population characteristics, before and during COVID 19 pandemia, Two groups of patients were compared from July 2019 to March 2020, and from July 2020 to March 2021, to evaluate the impact of COVID-19 in the history of the disease

Results There were included 422 cases , The prevalent stage observed was IIb (26%) and the median age was 44 years old (24 – 83). The mean tumor size was between 4 – 6cm. There were no statistically significant differences between the age groups or stage at diagnosis (92% were advanced in both groups). In the prepandemic one, 148 cases were recorded and 100 cases in the other. This number of patients appoiments decrease in the same period (32.43%, difference statistically significant - p=0.01). The mean follow-up was 380 days

Conclusion/Implications It was observed a high prevalence of advanced disease (92%) The COVID 19 pandemia decreased the number of consultations although no differences could be observed in the stage at the time of diagnosis ,in the pre and during the pandemia It is necessary to define effective treatment strategies and a public health plan